Brain mitochondrial impairment in early‐onset Parkinson's disease with or without PINK1 mutation

Background PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early‐onset Parkinson's disease, with or without PINK1 mutations. Methods We investigated brain intracellular pH, mitochondrial activity...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 35; no. 3; pp. 504 - 507
Main Authors Rango, Mario, Dossi, Gabriele, Squarcina, Letizia, Bonifati, Cristiana
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.03.2020
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0885-3185
1531-8257
1531-8257
DOI10.1002/mds.27946

Cover

Loading…
Abstract Background PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early‐onset Parkinson's disease, with or without PINK1 mutations. Methods We investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early‐onset Parkinson's disease with PINK1 mutations (n = 10), early‐onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex‐ and age‐matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate. Results The EOPD‐ group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD−. Conclusions Brain mitochondrial impairments were similar in early‐onset Parkinson's disease without PINK1 mutations and late‐onset Parkinson's disease. However, mitochondrial impairments were more severe in early‐onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society
AbstractList BackgroundPINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early‐onset Parkinson's disease, with or without PINK1 mutations.MethodsWe investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early‐onset Parkinson's disease with PINK1 mutations (n = 10), early‐onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex‐ and age‐matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate.ResultsThe EOPD‐ group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD−.ConclusionsBrain mitochondrial impairments were similar in early‐onset Parkinson's disease without PINK1 mutations and late‐onset Parkinson's disease. However, mitochondrial impairments were more severe in early‐onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society
PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early-onset Parkinson's disease, with or without PINK1 mutations.BACKGROUNDPINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early-onset Parkinson's disease, with or without PINK1 mutations.We investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early-onset Parkinson's disease with PINK1 mutations (n = 10), early-onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex- and age-matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate.METHODSWe investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early-onset Parkinson's disease with PINK1 mutations (n = 10), early-onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex- and age-matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate.The EOPD- group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD-.RESULTSThe EOPD- group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD-.Brain mitochondrial impairments were similar in early-onset Parkinson's disease without PINK1 mutations and late-onset Parkinson's disease. However, mitochondrial impairments were more severe in early-onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society.CONCLUSIONSBrain mitochondrial impairments were similar in early-onset Parkinson's disease without PINK1 mutations and late-onset Parkinson's disease. However, mitochondrial impairments were more severe in early-onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society.
PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early-onset Parkinson's disease, with or without PINK1 mutations. We investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early-onset Parkinson's disease with PINK1 mutations (n = 10), early-onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex- and age-matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate. The EOPD- group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD-. Brain mitochondrial impairments were similar in early-onset Parkinson's disease without PINK1 mutations and late-onset Parkinson's disease. However, mitochondrial impairments were more severe in early-onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society.
Background PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early‐onset Parkinson's disease, with or without PINK1 mutations. Methods We investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early‐onset Parkinson's disease with PINK1 mutations (n = 10), early‐onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex‐ and age‐matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate. Results The EOPD‐ group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD−. Conclusions Brain mitochondrial impairments were similar in early‐onset Parkinson's disease without PINK1 mutations and late‐onset Parkinson's disease. However, mitochondrial impairments were more severe in early‐onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society
Author Dossi, Gabriele
Rango, Mario
Squarcina, Letizia
Bonifati, Cristiana
Author_xml – sequence: 1
  givenname: Mario
  surname: Rango
  fullname: Rango, Mario
  email: mariocristia@yahoo.it
  organization: Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan
– sequence: 2
  givenname: Gabriele
  surname: Dossi
  fullname: Dossi, Gabriele
  organization: Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan
– sequence: 3
  givenname: Letizia
  surname: Squarcina
  fullname: Squarcina, Letizia
  organization: Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan
– sequence: 4
  givenname: Cristiana
  surname: Bonifati
  fullname: Bonifati, Cristiana
  organization: Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31898835$$D View this record in MEDLINE/PubMed
BookMark eNp1kUlOxDAQRS0EopthwQVQJBbAImDH8ZAlMy2aQQLWluO4hSGxGzsR6h1H4IycBPe0QbAqVfn9r3L9DbBqndUA7CB4hCDMjpsqHGWsyOkK6COCUcozwlZBH3JOUow46YGNEF4hRIggug56cVZwjkkflKdeGps0pnXqxdnKG1knphlL4xtt2yS-aenryffnl7NBt8mD9G_GBmf3Q1KZoGXQyYdpXxLnZ9V1kRnc3aCk6VrZGme3wNpI1kFvL-omeL68eDq7Tof3V4Ozk2GqMME05ZQqLnnOFOUVhWXOWIErLWVJIWGaqqyCRcFKiQiDpaK0ynDO8pGihYodwZvgYO479u6906EVjQlK17W02nVBZBhjCnFW5BHd-4W-us7buF2kGM0pKfKp4e6C6spGV2LsTSP9RCyvF4HjOaC8C8HrkVBm_uc2XrUWCIppPiLmI2b5RMXhL8XS9C924f5haj35HxS3549zxQ-wC59T
CitedBy_id crossref_primary_10_1016_j_arr_2023_102090
crossref_primary_10_1016_j_nbd_2020_105246
crossref_primary_10_1016_S1474_4422_21_00061_2
crossref_primary_10_1021_acschemneuro_3c00216
crossref_primary_10_3389_fnins_2021_660379
crossref_primary_10_3390_antiox12071411
crossref_primary_10_1016_j_bbabio_2022_148588
crossref_primary_10_1016_j_peptides_2021_170713
crossref_primary_10_12677_acm_2025_153781
crossref_primary_10_3390_ijms23137263
crossref_primary_10_1016_j_prp_2023_155023
crossref_primary_10_3389_fnins_2023_1116111
crossref_primary_10_1016_j_nbd_2020_105056
crossref_primary_10_3390_genes13030479
crossref_primary_10_1038_s41573_024_01105_0
crossref_primary_10_1016_j_arr_2024_102488
crossref_primary_10_1186_s10020_021_00426_9
crossref_primary_10_3389_fnagi_2021_690632
crossref_primary_10_1212_WNL_0000000000201288
crossref_primary_10_1002_ana_26884
crossref_primary_10_3389_fnins_2021_655901
crossref_primary_10_1155_2023_7759053
Cites_doi 10.1111/j.1468-1331.2008.02514.x
10.1242/jcs.078303
10.1002/ana.410320721
10.1016/S1474-4422(06)70411-2
10.1097/00004647-200101000-00011
10.1016/S1474-4422(06)70471-9
10.1111/apha.13068
10.1136/jnnp.55.3.181
10.1016/j.mito.2012.10.004
10.1007/s00415-011-6392-3
10.1017/cjn.2015.244
10.1038/sj.jcbfm.9600192
10.1038/jcbfm.1989.2
10.1016/j.parkreldis.2013.06.009
10.1152/advan.00045.2004
10.1016/j.sleep.2007.07.004
10.1016/j.neurobiolaging.2018.10.030
10.1002/ana.410280510
10.1073/pnas.0802076105
10.1126/science.3260686
10.1212/01.wnl.0000167546.39375.82
10.1016/j.neuro.2005.08.006
10.1212/01.WNL.0000163999.72864.FD
10.1111/jnc.13731
10.1002/mrm.1910380605
10.1002/mdc3.12501
10.1002/humu.20719
10.1073/pnas.1107332108
10.1016/j.parkreldis.2006.08.009
10.1212/WNL.17.5.427
ContentType Journal Article
Copyright 2020 International Parkinson and Movement Disorder Society
2020 International Parkinson and Movement Disorder Society.
Copyright_xml – notice: 2020 International Parkinson and Movement Disorder Society
– notice: 2020 International Parkinson and Movement Disorder Society.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
DOI 10.1002/mds.27946
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Genetics Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Nursing & Allied Health Premium
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8257
EndPage 507
ExternalDocumentID 31898835
10_1002_mds_27946
MDS27946
Genre shortCommunication
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3PY
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
YCJ
ZGI
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
ID FETCH-LOGICAL-c3536-866c8a847c68d60b47793deaab6057e6c2d0997ba1570bc66d23474fc69cc6653
IEDL.DBID DR2
ISSN 0885-3185
1531-8257
IngestDate Fri Jul 11 07:35:18 EDT 2025
Sun Jul 13 05:32:44 EDT 2025
Mon Jul 21 05:56:10 EDT 2025
Thu Apr 24 23:08:26 EDT 2025
Tue Jul 01 01:44:25 EDT 2025
Wed Jan 22 16:34:48 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords brain pH
brain mitochondrial functioning
phosphorus magnetic resonance spectroscopy (MRS)
early-onset Parkinson's disease (EOPD)
PINK1 gene mutation
Language English
License 2020 International Parkinson and Movement Disorder Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3536-866c8a847c68d60b47793deaab6057e6c2d0997ba1570bc66d23474fc69cc6653
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 31898835
PQID 2376465945
PQPubID 1016421
PageCount 4
ParticipantIDs proquest_miscellaneous_2333603294
proquest_journals_2376465945
pubmed_primary_31898835
crossref_citationtrail_10_1002_mds_27946
crossref_primary_10_1002_mds_27946
wiley_primary_10_1002_mds_27946_MDS27946
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2020
2020-03-00
20200301
PublicationDateYYYYMMDD 2020-03-01
PublicationDate_xml – month: 03
  year: 2020
  text: March 2020
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle Movement disorders
PublicationTitleAlternate Mov Disord
PublicationYear 2020
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2004; 302
2017; 4
2019; 75
2004; 28
2018; 223
1989; 9
2008; 9
2006; 5
2005; 64
2005; 65
2008; 105
1988; 241
2017; 132
1992; 32
1992; 55
2007; 13
2001; 21
2013; 19
2011; 124
2011; 108
2013; 13
1990; 28
2006; 27
2008; 29
2006; 26
2016; 43
1967; 17
1997; 38
2016; 139
2012; 259
2009; 16
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_16_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
Valente EM (e_1_2_8_15_1) 2004; 302
References_xml – volume: 32
  start-page: S125
  issue: S1
  year: 1992
  end-page: S127
  article-title: Criteria for diagnosing Parkinson's disease
  publication-title: Ann Neurol
– volume: 43
  start-page: 113
  issue: 1
  year: 2016
  end-page: 119
  article-title: Early‐onset vs. Late‐onset Parkinson's disease: A Clinical‐pathological Study
  publication-title: Can J Neurol Sci
– volume: 132
  year: 2017
– volume: 28
  start-page: 661
  issue: 5
  year: 1990
  end-page: 667
  article-title: Brain pH in head injury: an image‐guided 31P magnetic resonance spectroscopy study
  publication-title: Ann Neurol
– volume: 9
  start-page: 684
  issue: 6
  year: 2008
  end-page: 688
  article-title: Sleep quality in a family with hereditary parkinsonism (PARK6)
  publication-title: Sleep Med
– volume: 139
  start-page: 216
  year: 2016
  end-page: 231
  article-title: Mitochondrial dysfunction in Parkinson's disease
  publication-title: J Neurochem
– volume: 105
  start-page: 11364
  issue: 32
  year: 2008
  end-page: 11369
  article-title: Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
  publication-title: Proc Natl Acad Sci U S A
– volume: 108
  start-page: 12920
  issue: 31
  year: 2011
  end-page: 12924
  article-title: Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission
  publication-title: Proc Natl Acad Sci
– volume: 17
  start-page: 427
  issue: 5
  year: 1967
  end-page: 442
  article-title: Parkinsonism: onset, progression and mortality
  publication-title: Neurology
– volume: 9
  start-page: 2
  issue: 1
  year: 1989
  end-page: 19
  article-title: ATP and brain function
  publication-title: J Cereb Blood Flow Metab
– volume: 13
  start-page: 359
  issue: 6
  year: 2007
  end-page: 361
  article-title: Novel features in a patient homozygous for the L347P mutation in the PINK1 gene
  publication-title: Parkinsonism Relat Disord.
– volume: 75
  start-page: 224.e9
  year: 2019
  end-page: 224.e15
  article-title: Genetic variants of PARK genes in Korean patients with early‐onset Parkinson's disease
  publication-title: Neurobiol Aging
– volume: 5
  start-page: 525
  issue: 6
  year: 2006
  end-page: 535
  article-title: Epidemiology of Parkinson's disease
  publication-title: Lancet Neurol
– volume: 55
  start-page: 181
  issue: 3
  year: 1992
  end-page: 184
  article-title: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico‐pathological study of 100 cases
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 5
  start-page: 355
  issue: 4
  year: 2006
  end-page: 363
  article-title: Epidemiological, clinical, and genetic characteristics of early‐onset parkinsonism
  publication-title: Lancet Neurol
– volume: 223
  issue: 3
  year: 2018
  article-title: Roles of pH in control of cell proliferation
  publication-title: Acta Physiol
– volume: 16
  start-page: 450
  issue: 4
  year: 2009
  end-page: 456
  article-title: The effect of onset age on the clinical features of Parkinson's disease
  publication-title: Eur J Neurol
– volume: 13
  start-page: 59
  issue: 1
  year: 2013
  end-page: 61
  article-title: PINK1 parkinsonism and Parkinson disease: distinguishable brain mitochondrial function and metabolomics
  publication-title: Mitochondrion
– volume: 64
  start-page: 1958
  issue: 11
  year: 2005
  end-page: 1960
  article-title: The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease
  publication-title: Neurology
– volume: 241
  start-page: 462
  issue: 4864
  year: 1988
  end-page: 464
  article-title: Nonoxidative glucose consumption during focal physiologic neural activity
  publication-title: Science
– volume: 65
  start-page: 87
  issue: 1
  year: 2005
  end-page: 95
  article-title: Early‐onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
  publication-title: Neurology
– volume: 27
  start-page: 164
  issue: 2
  year: 2006
  end-page: 168
  article-title: Parkinson's disease, chronic hydrocarbon exposure and striatal neuronal damage: a 1‐H MRS study
  publication-title: Neurotoxicology
– volume: 19
  start-page: 961
  issue: 11
  year: 2013
  end-page: 965
  article-title: Gender and onset age‐related features of non‐motor symptoms of patients with Parkinson's disease ‐ A study from Southwest China
  publication-title: Park Relat Disord
– volume: 302
  start-page: 819
  issue: 5646
  year: 2004
  end-page: 822
  article-title: Molecular pathways of neurodegeneration in Parkinson's disease
  publication-title: Science
– volume: 28
  start-page: 160
  issue: 4
  year: 2004
  end-page: 179
  article-title: Regulation of intracellular pH
  publication-title: Adv Physiol Educ
– volume: 29
  start-page: 565
  issue: 4
  year: 2008
  end-page: 565
  article-title: PINK1 heterozygous rare variants: prevalence
  publication-title: significance and phenotypic spectrum. Hum Mutat
– volume: 21
  start-page: 85
  issue: 1
  year: 2001
  end-page: 91
  article-title: Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: a phosphorus magnetic resonance spectroscopy study
  publication-title: J Cereb Blood Flow Metab
– volume: 259
  start-page: 1639
  issue: 8
  year: 2012
  end-page: 1647
  article-title: Gender‐related differences in the burden of non‐motor symptoms in Parkinson's disease
  publication-title: J Neurol
– volume: 26
  start-page: 283
  issue: 2
  year: 2006
  end-page: 290
  article-title: Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study
  publication-title: J Cereb Blood Flow Metab.
– volume: 38
  start-page: 878
  issue: 6
  year: 1997
  end-page: 883
  article-title: Energetics of 3.5 s neural activation in humans: a 31P MR spectroscopy study
  publication-title: Magn Reson Med.
– volume: 4
  start-page: 499
  issue: 4
  year: 2017
  end-page: 508
  article-title: Genetic Identification in Early Onset Parkinsonism among Norwegian Patients
  publication-title: Mov Disord Clin Pract
– volume: 124
  start-page: 1115
  issue: 7
  year: 2011
  end-page: 1125
  article-title: Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance
  publication-title: J Cell Sci
– ident: e_1_2_8_6_1
  doi: 10.1111/j.1468-1331.2008.02514.x
– ident: e_1_2_8_17_1
  doi: 10.1242/jcs.078303
– ident: e_1_2_8_2_1
  doi: 10.1002/ana.410320721
– ident: e_1_2_8_5_1
  doi: 10.1016/S1474-4422(06)70411-2
– ident: e_1_2_8_24_1
  doi: 10.1097/00004647-200101000-00011
– ident: e_1_2_8_4_1
  doi: 10.1016/S1474-4422(06)70471-9
– ident: e_1_2_8_29_1
  doi: 10.1111/apha.13068
– ident: e_1_2_8_19_1
  doi: 10.1136/jnnp.55.3.181
– ident: e_1_2_8_18_1
  doi: 10.1016/j.mito.2012.10.004
– ident: e_1_2_8_3_1
  doi: 10.1007/s00415-011-6392-3
– ident: e_1_2_8_7_1
  doi: 10.1017/cjn.2015.244
– ident: e_1_2_8_13_1
  doi: 10.1038/sj.jcbfm.9600192
– ident: e_1_2_8_25_1
  doi: 10.1038/jcbfm.1989.2
– ident: e_1_2_8_8_1
  doi: 10.1016/j.parkreldis.2013.06.009
– ident: e_1_2_8_28_1
  doi: 10.1152/advan.00045.2004
– ident: e_1_2_8_32_1
  doi: 10.1016/j.sleep.2007.07.004
– ident: e_1_2_8_10_1
  doi: 10.1016/j.neurobiolaging.2018.10.030
– ident: e_1_2_8_23_1
  doi: 10.1002/ana.410280510
– ident: e_1_2_8_16_1
  doi: 10.1073/pnas.0802076105
– ident: e_1_2_8_26_1
  doi: 10.1126/science.3260686
– ident: e_1_2_8_14_1
  doi: 10.1212/01.wnl.0000167546.39375.82
– volume: 302
  start-page: 819
  issue: 5646
  year: 2004
  ident: e_1_2_8_15_1
  article-title: Molecular pathways of neurodegeneration in Parkinson's disease
  publication-title: Science
– ident: e_1_2_8_21_1
  doi: 10.1016/j.neuro.2005.08.006
– ident: e_1_2_8_31_1
  doi: 10.1212/01.WNL.0000163999.72864.FD
– ident: e_1_2_8_11_1
  doi: 10.1111/jnc.13731
– ident: e_1_2_8_22_1
  doi: 10.1002/mrm.1910380605
– ident: e_1_2_8_12_1
– ident: e_1_2_8_9_1
  doi: 10.1002/mdc3.12501
– ident: e_1_2_8_33_1
  doi: 10.1002/humu.20719
– ident: e_1_2_8_27_1
  doi: 10.1073/pnas.1107332108
– ident: e_1_2_8_30_1
  doi: 10.1016/j.parkreldis.2006.08.009
– ident: e_1_2_8_20_1
  doi: 10.1212/WNL.17.5.427
SSID ssj0011516
Score 2.426523
Snippet Background PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with...
PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early-onset...
BackgroundPINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 504
SubjectTerms Adenosine triphosphate
Age of Onset
Brain - diagnostic imaging
brain mitochondrial functioning
brain pH
early‐onset Parkinson's disease (EOPD)
Humans
Intracellular
Magnetic resonance spectroscopy
Mitochondria
Mitochondria - genetics
Movement disorders
Mutation
Mutation - genetics
Neurodegenerative diseases
Parkinson Disease - complications
Parkinson Disease - genetics
Parkinson's disease
pH effects
Phosphocreatine
phosphorus magnetic resonance spectroscopy (MRS)
PINK1 gene mutation
Protein Kinases - genetics
PTEN-induced putative kinase
Title Brain mitochondrial impairment in early‐onset Parkinson's disease with or without PINK1 mutation
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.27946
https://www.ncbi.nlm.nih.gov/pubmed/31898835
https://www.proquest.com/docview/2376465945
https://www.proquest.com/docview/2333603294
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VPaBeoNACCy1yUSV6yTbrVxJxKoWqgLYHaKUeKkV-rYRgs9Xu5sKJn8Bv5Jcw4zyq0lZCPSWRJ7Fjz9hjz8w3ALvcFM5nIU8mQtpE-tQnNuRkLhTB54pPfEzTOT7Rx2fy07k6X4G3XSxMgw_RH7iRZMT5mgTc2MX-FWjo1C-GnODRcf4lXy1SiL700FGo6MS0pyhEKkYId6hCKd_v37y-Ft1QMK_rq3HBOXoEF11TGz-T78N6aYfu5z8ojvf8l3V42Cqi7KDhnMewEqon8GDcmto3wL6j5BFsihKPM2TliVEZxVR-m9OBIsOyQODIf379JofsJaP46RhK9mbBWrMPo1NeNpvH66xGmo8nn0dsWjf2_004O_pwenictAkZEicUARdr7XKD65nTudeplRlKtw_GWNwUZUE77ikQ15qRylLrtPZcyExOnC4cPinxFFarWRWeA5toH_ArhbLWSTMaFUZkxlDyE40aES8GsNcNTelatHJKmvGjbHCWeYl9VsY-G8DrnvSygei4jWirG9-ylVIswdlValVINYCdvhjli4wmpgqzmmiE0KnghRzAs4Yv-lqQr4ocVVhsbBzdu6svx--_xpsX_0_6EtY4be6jw9sWrC7nddhGDWhpX0VW_wvKwwJD
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61RaJcKG-WluJWSOWSbdZ2nETiQinV9rE99CH1giK_VqrKZtF2c-HET-A38kuYcR5VoUiIUxJ5EjueGXvs8XwD8Jbr3LrUZ9FYSBNJF7vI-IzchcK7LOFjF9J0jo7V8FweXCQXC_C-jYWp8SG6DTfSjDBek4LThvT2DWroxF33OeGjL8I9yuhN-Qt2TzrwKDR1QuJTVKMkxAi3uEIx3-5evT0b_WFi3rZYw5SztwKf28bWJ02u-tXc9O2333Ac__dvHsHDxhZlH2rheQwLvnwC90eNt_0pmB3KH8EmqPQ4SJaOZJVRWOXljPYUGZZ5wkf--f0HncmeMwqhDtFkW9es8fww2uhl01m4Tiuk2T8-HLBJVR8BeAbne5_OPg6jJidDZEVC2MVK2UzjlGZV5lRsZIoK7rzWBtdFqVeWO4rFNXqQpLGxSjkuZCrHVuUWnxLxHJbKaelfAhsr5_EreWKMlXowyLVItab8JwqNIp734F3Lm8I2gOWUN-NLUUMt8wL7rAh91oPNjvRrjdJxF9Fay-CiUVQswQEWhSeXSQ82umJUMfKb6NJPK6IRQsWC57IHL2rB6GpBwcoztGKxsYG9f6--GO2ehptX_076BpaHZ6Oj4ghZswoPOK31w_m3NViazyr_Gg2iuVkPcv8L3ogGXQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcWt5dKGAQElyyzfqVRJyAsiqPrRBQqQekyK9IVdlstd1ceuIn8Bv5Jcw4D1QeEuKURJ7EjmfGHns83wA85qZwPgt5UglpE-lTn9iQk7tQBJ8rXvmYpnN2oPcP5ZsjdbQGz_pYmBYfYthwI82I4zUp-Kmvdn-Chs792ZgTPPoluCw1KgtZRB8G7Ci0dGLeUyxQMUS4hxVK-e7w6sXJ6DcL86LBGmec6RZ87tvaHjQ5GTcrO3bnv8A4_ufPXIXNzhJlz1vRuQZrob4OG7PO134D7AvKHsHmqPI4RNaeJJVRUOXxknYUGZYFQkf-_vUbncheMQqgjrFkT85Y5_dhtM3LFst4XTRI8_rg7YTNm_YAwE04nL769HI_6TIyJE4oQi7W2uUGJzSnc69TKzNUbx-MsbgqyoJ23FMkrjUTlaXWae25kJmsnC4cPilxC9brRR22gVXaB_xKoax10kwmhRGZMZT9RKNJxIsRPO1ZU7oOrpyyZnwpW6BlXmKflbHPRvBoID1tMTr-RLTT87fs1BRLcHiVWhVSjeDhUIwKRl4TU4dFQzRC6FTwQo7gdisXQy0oV0WONiw2NnL379WXs72P8ebOv5M-gI33e9PyHXLmLlzhtNCPh992YH21bMI9tIZW9n6U-h_n5QUV
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Brain+Mitochondrial+Impairment+in+Early%E2%80%90Onset+Parkinson%27s+Disease+With+or+Without+PINK1+Mutation&rft.jtitle=Movement+disorders&rft.au=Rango%2C+Mario&rft.au=Dossi%2C+Gabriele&rft.au=Squarcina%2C+Letizia&rft.au=Bonifati%2C+Cristiana&rft.date=2020-03-01&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=35&rft.issue=3&rft.spage=504&rft.epage=507&rft_id=info:doi/10.1002%2Fmds.27946&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_mds_27946
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon